Drug Shortage Report for ROPIVACAINE HYDROCHLORIDE INJECTION, USP
| Report ID | 257455 |
| Drug Identification Number | 02439409 |
| Brand name | ROPIVACAINE HYDROCHLORIDE INJECTION, USP |
| Common or Proper name | ROPIVACAINE HYDROCHLORIDE INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | ROPIVACAINE HYDROCHLORIDE |
| Strength(s) | 10MG |
| Dosage form(s) | SOLUTION |
| Route of administration | EPIDURAL EPIDURAL |
| Packaging size | 20 mL |
| ATC code | N01BB |
| ATC description | ANESTHETICS, LOCAL |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2025-06-01 |
| Actual start date | |
| Estimated end date | 2025-12-08 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-11-18 |
| Company comments | Fresenius Kabi Canada regrets to advise that, due to production delays, we will be encountering a supply interruption. |
| Health Canada comments | |
| Tier 3 Status | Yes |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2025-11-18 | English | Compare |
| v7 | 2025-11-11 | French | Compare |
| v6 | 2025-11-11 | English | Compare |
| v5 | 2025-09-23 | French | Compare |
| v4 | 2025-09-23 | English | Compare |
| v3 | 2025-06-02 | English | Compare |
| v2 | 2025-05-15 | French | Compare |
| v1 | 2025-05-15 | English | Compare |
Showing 1 to 8 of 8